These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39279053)

  • 1. Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathology.
    Lin PH; Yao HY; Huang L; Fu CC; Yao XL; Lian C; Zhang SF; Lai WD; Lin GY; Liao S; Yang J; Mao ZF; Liu D; Long BY; Yue JJ; Gao C; Long YM
    CNS Neurosci Ther; 2024 Sep; 30(9):e70042. PubMed ID: 39279053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytic damage in glial fibrillary acidic protein astrocytopathy during initial attack.
    Yang X; Huang Q; Yang H; Liu S; Chen B; Liu T; Yang J; Yao H; Lin S; Chen X; Zhuang H; Long Y; Gao C
    Mult Scler Relat Disord; 2019 Apr; 29():94-99. PubMed ID: 30690341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
    Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij HB; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
    Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune glial fibrillary acidic protein astrocytopathy with anti-NMDAR and sulfatide-IgG-positive encephalitis overlap syndrome: A case report and literature review.
    Cui RM; Fan FR; Ma SH; Li H; Li JC; Wen Y; Liu MW
    Medicine (Baltimore); 2024 Jul; 103(28):e38983. PubMed ID: 38996095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, immunological alteration and distinction of MOG-IgG-associated disorders and GFAP-IgG-associated disorders.
    Zeng R; He L; Kuang Z; Jian Y; Qiu M; Liu Y; Hu M; Ye Y; Wu L
    J Neuroimmunol; 2024 Aug; 393():578398. PubMed ID: 39002186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.
    Fang B; McKeon A; Hinson SR; Kryzer TJ; Pittock SJ; Aksamit AJ; Lennon VA
    JAMA Neurol; 2016 Nov; 73(11):1297-1307. PubMed ID: 27618707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients.
    Li T; Li X; Hong S; Jiang L; Ma J
    J Neuroimmunol; 2023 Sep; 382():578176. PubMed ID: 37572437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature.
    Shan F; Long Y; Qiu W
    Front Immunol; 2018; 9():2802. PubMed ID: 30568655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease.
    Wilms AE; de Boer I; Pelzer N; In't Veld SGJG; Middelkoop HAM; Teunissen CE; Terwindt GM
    J Neurol; 2024 Jul; 271(7):4138-4145. PubMed ID: 38581544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting with Area Postrema Syndrome-Like Symptoms without Medulla Oblongata Lesions.
    Iwami K; Nomura T; Seo S; Nojima S; Tsuzaka K; Kimura A; Shimohata T; Yabe I
    Neuroimmunomodulation; 2022; 29(4):433-438. PubMed ID: 35421859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
    Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
    Front Immunol; 2021; 12():647618. PubMed ID: 33796113
    [No Abstract]   [Full Text] [Related]  

  • 13. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.
    Flanagan EP; Hinson SR; Lennon VA; Fang B; Aksamit AJ; Morris PP; Basal E; Honorat JA; Alfugham NB; Linnoila JJ; Weinshenker BG; Pittock SJ; McKeon A
    Ann Neurol; 2017 Feb; 81(2):298-309. PubMed ID: 28120349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalitis with radial perivascular emphasis: Not necessarily associated with GFAP antibodies.
    Wickel J; Chung HY; Kirchhof K; Boeckler D; Merkelbach S; Kuzman P; Mueller WC; Geis C; Günther A
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32019875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
    Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
    Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
    Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
    J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
    Schindler P; Aktas O; Ringelstein M; Wildemann B; Jarius S; Paul F; Ruprecht K
    Expert Rev Clin Immunol; 2023 Jan; 19(1):71-91. PubMed ID: 36378751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG
    Xiao J; Zhang SQ; Chen X; Tang Y; Chen M; Shang K; Deng G; Qin C; Tian DS
    Mult Scler Relat Disord; 2022 Oct; 66():104057. PubMed ID: 35870369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy in Children: A Retrospective Analysis of 35 Cases.
    Fang H; Hu W; Jiang Z; Yang H; Liao H; Yang L; Wu L
    Front Immunol; 2021; 12():761354. PubMed ID: 34880859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease.
    Syk M; Tornvind E; Gallwitz M; Fällmar D; Amandusson Å; Rothkegel H; Danfors T; Thulin M; Rasmusson AJ; Cervenka S; Pollak TA; Endres D; van Elst LT; Bodén R; Nilsson BM; Nordmark G; Burman J; Cunningham JL
    Transl Psychiatry; 2024 Jul; 14(1):304. PubMed ID: 39048548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.